The introduction of disease modifying amyloid targeting therapies for Alzheimer’s disease is creating a paradigm shift in the treatment of patients with this condition. But the potential for ARIA prompts several unique considerations over the course of therapy. This curriculum is designed to outline critical roles and best practices in ARIA identification and management across disciplines to prepare you to navigate real-world clinical scenarios.
